Management of infusion-related reactions (IRRs) in patients (pts) receiving daratumumab plus standard of care for the treatment of multiple myeloma (MM) in the phase 3 studies CASTOR and POLLUX

Article2020

MM-339: Effect of Lenalidomide (R) ± Dexamethasone (d) Discontinuation on Daratumumab Efficacy in Multiple Myeloma (MM): Subgroup Analysis of the Phase 3 MAIA and POLLUX Studies

Philippe Moreau, Thierry Façon, Saad Z. Usmani, Meletios A Dimopoulos, Shaji Kumar, Torben Plesner, Hartmut Goldschmidt, Donna Reece, Robert Z. Orlowski, Aurore Perrot, Merav Leiba, Ajai Chari, Jesús F. San Miguel, Gordon Cook, Shinsuke Iida, Huiling Pei, Rian Van Rampelbergh, Clarissa Uhlar, Thomas Renaud, Jon Ukropec, Rachel Kobos, Nizar J. Bahlis

Article2021

Health‐related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial

Torben Plesner, Meletios A Dimopoulos, Albert Oriol, Jesús F. San Miguel, Nizar J. Bahlis, Neil Rabin, Kenshi Suzuki, Sung‐Soo Yoon, Dina Ben‐Yehuda, Gordon Cook, Hartmut Goldschmidt, Sebastian Grosicki, Xiang Qin, John Fastenau, Wendy Garvin, Robin Carson, Thomas Renaud, Katharine S. Gries

Article2017

Safety and efficacy of daratumumab-based regimens in elderly (≥75 y) patients (Pts) with relapsed or refractory multiple myeloma (RRMM): Subgroup analysis of POLLUX and CASTOR.

María‐Victoria Mateos, Andrew Spencer, Ajay K. Nooka, Luděk Pour, Katja Weisel, Michèle Cavo, Jacob P. Laubach, Gordon Cook, Shinsuke Iida, Lotfi Benboubker, Saad Z. Usmani, Sung‐Soo Yoon, Nizar J. Bahlis, Christopher Chiu, Jordan M. Schecter, Kaida Wu, Xiang Qin, David Soong, Meletios A Dimopoulos

Article2020

Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study

Nizar J. Bahlis, Meletios A Dimopoulos, Darrell White, Lotfi Benboubker, Gordon Cook, Merav Leiba, P. Joy Ho, Kihyun Kım, Naoki Takezako, Philippe Moreau, Jonathan L. Kaufman, Maria Krevvata, Christopher Chiu, Xiang Qin, Linda Okonkwo, Sonali Trivedi, Jon Ukropec, Ming Qi, Jesús F. San Miguel

Article2018

Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX study

Kenshi Suzuki, Meletios A Dimopoulos, Naoki Takezako, Shinichiro Okamoto, Atsushi Shinagawa, Morio Matsumoto, Hiroshi Kosugi, Sung‐Soo Yoon, Shang‐Yi Huang, Xiang Qin, Ming Qi, Shinsuke Iida

Discussion(0)

Related publications